HypOxygen's Blog - Latest News from HypOxygen

Hypoxia and Immunity

immunity imageThe upcoming Cell symposium will shine a spotlight on research delineating the complex cross-talk between inflammatory processes, immune response and the development of cancer diseases. At “Cancer, Inflammation and Immunity” on June 14-16 in Sitges, Spain, Don Whitley Scientific will be exhibiting the HypOxystation controlled environment workstation for low oxygen cell culture. As we look forward to the conference, Dr Burga Kalz Fuller, Product Manager at our American distributor, HypOxygen, has summarized five interesting and recent papers concerning hypoxia and its role in immunology and cancer research:

Read more: Hypoxia and Immunity

Mitochondria and a Three-Person Baby

Schematic 1 300x300

Last week, the House of Commons voted to allow in vitro fertilisation (IVF) to be carried out with eggs from two different women and sperm from one man, a technique which has been dubbed the “three-person baby”. The vote opened a novel avenue for treating mitochondrial diseases because the actual nuclear mother, whose family would have a history of mitochondrial (MT) diseases, does not pass on her mitochondria, with the baby receiving the female donor’s healthy mitochondria instead.

Read more: Mitochondria and a Three-Person Baby

HypOxygen and Don Whitley Scientific Support Keystone Symposia


HypOxygen and Don Whitley Scientific are sponsoring a series of Keystone Symposia dealing with tumor micro environment (Vancouver), mitochondria and metabolism (Santa Fe), and immunity and inflammation (Olympic Valley). We are interested in the research being presented at these conferences because physiologically normoxic conditions in all these fields are at much lower oxygen tension (<5%) than ambient. So when cell culture and incubation are carried out at 21%, the cells are being blasted with oxygen that really prevents any sort of physiologically correct behavior at a cellular and sub cellular level. 

Read more: HypOxygen and Don Whitley Scientific Support Keystone Symposia

HypOxygen Strengthens Resources

Dr Burga Kalz Fuller

HypOxygen announced on September 8th 2014, that Burga Kalz Fuller, PhD has joined the firm to further enhance their penetration of the HypOxystation hypoxic workstation and related products into the growing field of mammalian cell based hypoxia research.

Burga comes with a wealth of experience within the Life Sciences Industry, having spent the last ten years working with technology suppliers both in Europe and the United States where she was instrumental in the technical supervision of product and equipment development and marketing strategies.

Burga joins HypOxygen as Product Manager to continue HypOxygen's recent success in providing state of the art hypoxic workstations that lead the way in advancing scientific research and innovation.

Read more: HypOxygen Strengthens Resources